[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SU628930A1 - Устройство дл введени порошкообразного лекарственного вещества - Google Patents

Устройство дл введени порошкообразного лекарственного вещества

Info

Publication number
SU628930A1
SU628930A1 SU742097190A SU2097190A SU628930A1 SU 628930 A1 SU628930 A1 SU 628930A1 SU 742097190 A SU742097190 A SU 742097190A SU 2097190 A SU2097190 A SU 2097190A SU 628930 A1 SU628930 A1 SU 628930A1
Authority
SU
USSR - Soviet Union
Prior art keywords
medicinal powders
introducing medicinal
introducing
powders
cavity
Prior art date
Application number
SU742097190A
Other languages
English (en)
Inventor
Иван Михайлович Бондарев
Original Assignee
Московский научно-исследовательский институт туберкулеза
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Московский научно-исследовательский институт туберкулеза filed Critical Московский научно-исследовательский институт туберкулеза
Priority to SU742097190A priority Critical patent/SU628930A1/ru
Application granted granted Critical
Publication of SU628930A1 publication Critical patent/SU628930A1/ru

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

При практическом использовании устройства уровень порошка а емкости  е превышает половины длины цек;гральной трубки. .Подсоединение емкости с лекарственным препаратом к игле производ т при сжатой груше , что обеспечивает в первой фазе работы засасывание воздуха нз каверны в емкость дл  лекарственного пред рата, а при второй фазе (сжатии) порошок, увлекаемый тем же объемом eosjGiyxa, выталкиваетс  в каверну .
Описанное устройство обеспечивает введ ние лекарственного препарата в  атологнческую полость с использованием мнниMaJibHoro объема воздуха дл  устранени  перераст женн  стенок полости.

Claims (2)

1.Авторское свидетельство СССР № 171094, кл. А 61 М 13/00, 1964.
2.Патент Франции № 2004243, кл. В 05 В И/00, 1969.
SU742097190A 1974-11-26 1974-11-26 Устройство дл введени порошкообразного лекарственного вещества SU628930A1 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU742097190A SU628930A1 (ru) 1974-11-26 1974-11-26 Устройство дл введени порошкообразного лекарственного вещества

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU742097190A SU628930A1 (ru) 1974-11-26 1974-11-26 Устройство дл введени порошкообразного лекарственного вещества

Publications (1)

Publication Number Publication Date
SU628930A1 true SU628930A1 (ru) 1978-10-25

Family

ID=20607598

Family Applications (1)

Application Number Title Priority Date Filing Date
SU742097190A SU628930A1 (ru) 1974-11-26 1974-11-26 Устройство дл введени порошкообразного лекарственного вещества

Country Status (1)

Country Link
SU (1) SU628930A1 (ru)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5740794A (en) * 1994-09-21 1998-04-21 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US6089228A (en) * 1994-09-21 2000-07-18 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US6679256B2 (en) 1999-12-17 2004-01-20 Nektar Therapeutics Systems and methods for extracting powders from receptacles
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
WO2006088894A2 (en) 2005-02-15 2006-08-24 Elan Pharma International Limited Aerosol and injectable formulations of nanoparticulate benzodiazepine
EP2263652A1 (en) 1998-11-12 2010-12-22 Elan Pharma International Limited Aerosols comprising nanoparticle drugs
US8161969B2 (en) 1998-06-04 2012-04-24 Novartis Ag Dry powder dispersing apparatus and methods for their use
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US8357696B2 (en) 2005-05-18 2013-01-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2594272A2 (en) 2005-05-18 2013-05-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9700529B2 (en) 2002-05-03 2017-07-11 Nektar Therapeutics Particulate materials
US9700564B2 (en) 2009-09-04 2017-07-11 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US11980689B2 (en) 2013-07-31 2024-05-14 Avalyn Pharma Inc. Inhaled imatinib for treatment of pulmonary arterial hypertension (PAH)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US6089228A (en) * 1994-09-21 2000-07-18 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US5740794A (en) * 1994-09-21 1998-04-21 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US5993783A (en) * 1995-04-14 1999-11-30 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder α1-antitrypsin
US8161969B2 (en) 1998-06-04 2012-04-24 Novartis Ag Dry powder dispersing apparatus and methods for their use
EP2263652A1 (en) 1998-11-12 2010-12-22 Elan Pharma International Limited Aerosols comprising nanoparticle drugs
US6679256B2 (en) 1999-12-17 2004-01-20 Nektar Therapeutics Systems and methods for extracting powders from receptacles
US10188614B2 (en) 2002-05-03 2019-01-29 Nektar Therapeutics Particulate materials
US10945972B2 (en) 2002-05-03 2021-03-16 Nektar Therapeutics Particulate materials
US9700529B2 (en) 2002-05-03 2017-07-11 Nektar Therapeutics Particulate materials
EP2353590A1 (en) 2005-02-15 2011-08-10 Elan Pharma International Limited Aerosol and injectable formulations of nanoparticulate benzodiazepine
WO2006088894A2 (en) 2005-02-15 2006-08-24 Elan Pharma International Limited Aerosol and injectable formulations of nanoparticulate benzodiazepine
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2594272A2 (en) 2005-05-18 2013-05-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US10987357B2 (en) 2005-05-18 2021-04-27 Horizon Orphan, LLC Aerosolized fluoroquinolones and uses thereof
US8357696B2 (en) 2005-05-18 2013-01-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US10149854B2 (en) 2008-10-07 2018-12-11 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9717738B2 (en) 2008-10-07 2017-08-01 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9326936B2 (en) 2008-10-07 2016-05-03 Raptor Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
US10722519B2 (en) 2008-10-07 2020-07-28 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
US11020481B2 (en) 2008-10-07 2021-06-01 Horizon Orphan Llc Topical use of levofloxacin for reducing lung inflammation
US9700564B2 (en) 2009-09-04 2017-07-11 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US10231975B2 (en) 2009-09-04 2019-03-19 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US10792289B2 (en) 2009-09-04 2020-10-06 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP4059499A1 (en) 2011-01-31 2022-09-21 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US11980689B2 (en) 2013-07-31 2024-05-14 Avalyn Pharma Inc. Inhaled imatinib for treatment of pulmonary arterial hypertension (PAH)

Similar Documents

Publication Publication Date Title
SU628930A1 (ru) Устройство дл введени порошкообразного лекарственного вещества
AR202163A1 (es) Dispositivo quirurgico tubular, destinado a ser introducido temporariamente en las cavidades de un cuerpo vivo
BE827127A (fr) Nouveaux derives d'acide oxy-16 prostanoique, leur procede de preparation et leur utilisation therapeutique
IE45048L (en) Syringe.
BE860726A (fr) Nouveaux aryl-acylamides n-(2-aminocy-cloaliphatiques), leur procede de preparation et medicament les contenant
JPS52151720A (en) Apparatus for preparing and administering plantable medicine
GB1335797A (en) Multiple dosage inoculator
BE827777A (fr) Nouveaux amides d'acides carboxyliques, leur procede de preparation et medicament les contenant
ZA752067B (en) Process for preparing a pharmaceutical preparation containing zinc-zn suitable for medical use
FR2276048A1 (fr) Nouveaux esters du cyclohexanol, leurs sels, leur preparation et les medicaments qui les renferment
BE848310A (fr) Acides di(phenoxy-2 alcane carboxyliques), leur procede de preparation et leur utilisation comme medicaments
BE794414A (fr) Nouveaux amino-alcools, leur preparation et leur application comme medicament
BE826709A (fr) Nouveaux composes heterocycliques, leur preparation et medicament les contenant
NL183582B (nl) Werkwijze voor de bereiding van een geneesmiddel met anti-inflammatoire, analgetische en anti-reumatische werking, aldus verkregen geneesmiddel en werkwijze voor de bereiding van hiervoor geschikte verbindingen.
BE786713A (fr) Nouveaux amino-alcools, leur preparation et leur application comme medicaments
FR2346005A1 (fr) Nouvelles lactones d'acides libres du type prostaglandine, leur procede de preparation et medicament les contenant
NL7514620A (nl) Werkwijze ter bereiding van een geneesmiddel met werking bij nerveuse en psychosomatische aandoe- ningen, zo gevormd geneesmiddel en werkwijze ter bereiding van daartoe geschikte actieve verbin- dingen.
IL46687A0 (en) Novel-n-sulphenylated oxime-carbamates,their preparation and their use as insecticides,acaricides and nematicides
BE861697A (fr) Nouveaux antibiotiques polycycliques, leur procede de preparation et medicament les contenant
FR2281109A1 (fr) Amides de l'acide cinnamique, leur preparation et medicament contenant ces substances
NL7507422A (nl) Werkwijze voor de bereiding van een geneesmiddel met bloeddrukverlagende werking, een dergelijk ge- neesmiddel en een werkwijze voor de bereiding van de actieve verbindingen.
CA1029305A (en) Infusion solution for the treatment of tachycardiac disturbances of heart rhythm and use thereof
FR2274288A1 (fr) Nouveaux composes arylsulfonylcarbamoyl-1,3-dicarbonyliques, leur procede de preparation et medicament les contenant
Nassberg et al. Physiological salpingitis
FR2292483A1 (fr) Nouveau derive de la butirosine a, son procede de preparation et medicament le contenant